PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA; Department of Family Medicine, Oregon Health and Science University, Portland, OR, USA. Electronic address: buchheit@ohsu.edu.\', \'Outside In Injection Drug Users Health Services, Portland, OR, USA.\', \'Department of Medicine, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0740-5472(21)00170-710.1016/j.jsat.2021.108444
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 34098299
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34098299>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34098299>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all